NEW YORK, March 12, 2015 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Acadia Pharmaceuticals Inc. ("Acadia" or the "Company") (NasdaqGS: ACAD -News). Such investors are advised to contact Peretz Bronstein or his investor relations coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.
The investigation concerns whether Acadia. and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On March 11, 2015, the drug maker announced that it would delay submitting a new-drug application for Nuplazid until later this year. The company also said that Chief Executive Uli Hacksell is retiring. The Company had originally planned to submit the application in the first quarter.
On this news, shares of Acadia fell $9.97 or 22.27% during intraday trading to trade at $34.79 on March 12, 2015.
If you are aware of any facts relating to this investigation, or purchased shares of Acadia, you can assist this investigation by contacting Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
info@bgandg.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-acadia-pharmaceuticals-inc-300049750.html
SOURCE Bronstein, Gewirtz & Grossman, LLC